Review



anti brca2 rabbit  (Bethyl)


Bioz Verified Symbol Bethyl is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bethyl anti brca2 rabbit
    Anti Brca2 Rabbit, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 88 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/BRCA2+Antibody/pmc12934461-8-0-3
    Average 94 stars, based on 88 article reviews
    anti brca2 rabbit - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: Synergistic protection of nascent DNA at stalled forks by MSANTD4 and BRCA1/2-RAD51.
    Article Snippet: The regressed arms of reversed replication forks exhibit structural similarities to one-ended double-stranded breaks and need to be protected against uncontrolled nucleolytic degradation.. Here, we identify MSANTD4 (Myb/SANT-like DNA-binding domain-containing protein 4), a functionally uncharacterized protein that uniquely counters the replication protein A (RPA)–Bloom (BLM)/Werner syndrome helicase (WRN)–DNA replication helicase/nuclease 2 (DNA2) complex to safeguard reversed replication forks from detrimental degradation, independently of the breast cancer susceptibility proteins (BRCA1/2)–DNA repair protein RAD51 pathway.. MSANTD4 specifically interacts with the junctions between single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) in DNA substrates harboring a 3′ overhang, which resemble the structural features of regressed arms processed by WRN–DNA2.

    Article Title: PARP1 UFMylation ensures the stability of stalled replication forks
    Article Snippet: .. Immunoblotting, immunoprecipitation, pull-down assays and immunofluorescence First antibodies: anti-HA (A190-208A), anti-MYC (A190-205A), anti-UFL1 (A303455A, A303-456A), anti-PARP1 (A301-375A), anti-CHK1 (A300-298A), anti-BRCA2 (A303-434A), anti-RPA32 (A300-244A), and anti-pRPA32 (S33) (A300-246A) were purchased from Bethyl. .. Anti-PAR (ab14459), anti-BrdU (ab6326), anti-H3 (ab1791), and anti-MRE11 (ab214) was purchased from Abcam.

    Article Title: TFIP11 promotes replication fork reversal to preserve genome stability
    Article Snippet: Anti-PCNA (PC10) (sc-56, WB dilution: 1:1000) and anti-Flag (M2, WB dilution: 1:5000, immunostaining dilution: 1:1000) antibodies were purchased from Santa Cruz Biotechnology and Sigma-Aldrich, respectively. .. Anti-BRCA2 (A303-434A, WB dilution: 1:2000), anti-Biotin (150–109 A, immunostaining dilution: 1:3000) and anti-RMI1 (A300-631A, WB dilution:1:1000), and anti-BRCA1 (A301-378A, WB dilution: 1:1000) antibodies were purchased from Bethyl. .. Anti-IdU/BrdU (B44) (347580, immunostaining dilution: 1:500) antibody was purchased from BD Biosciences.

    Article Title: UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells.
    Article Snippet: The stabilization of stalled forks has emerged as a crucial mechanism driving resistance to poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2-deficient tumors.. Here, we identify UFL1, a UFM1-specific E3 ligase, as a pivotal regulator of fork stability and the response to PARP inhibitors in BRCA1/2-deficient cells.. On replication stress, UFL1 localizes to stalled forks and catalyzes the UFMylation of PTIP, a component of the MLL3/4 methyltransferase complex, specifically at lysine 148.

    Immunostaining:

    Article Title: Synergistic protection of nascent DNA at stalled forks by MSANTD4 and BRCA1/2-RAD51.
    Article Snippet: The regressed arms of reversed replication forks exhibit structural similarities to one-ended double-stranded breaks and need to be protected against uncontrolled nucleolytic degradation.. Here, we identify MSANTD4 (Myb/SANT-like DNA-binding domain-containing protein 4), a functionally uncharacterized protein that uniquely counters the replication protein A (RPA)–Bloom (BLM)/Werner syndrome helicase (WRN)–DNA replication helicase/nuclease 2 (DNA2) complex to safeguard reversed replication forks from detrimental degradation, independently of the breast cancer susceptibility proteins (BRCA1/2)–DNA repair protein RAD51 pathway.. MSANTD4 specifically interacts with the junctions between single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) in DNA substrates harboring a 3′ overhang, which resemble the structural features of regressed arms processed by WRN–DNA2.

    Article Title: TFIP11 promotes replication fork reversal to preserve genome stability
    Article Snippet: Anti-PCNA (PC10) (sc-56, WB dilution: 1:1000) and anti-Flag (M2, WB dilution: 1:5000, immunostaining dilution: 1:1000) antibodies were purchased from Santa Cruz Biotechnology and Sigma-Aldrich, respectively. .. Anti-BRCA2 (A303-434A, WB dilution: 1:2000), anti-Biotin (150–109 A, immunostaining dilution: 1:3000) and anti-RMI1 (A300-631A, WB dilution:1:1000), and anti-BRCA1 (A301-378A, WB dilution: 1:1000) antibodies were purchased from Bethyl. .. Anti-IdU/BrdU (B44) (347580, immunostaining dilution: 1:500) antibody was purchased from BD Biosciences.

    Article Title: UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells.
    Article Snippet: The stabilization of stalled forks has emerged as a crucial mechanism driving resistance to poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2-deficient tumors.. Here, we identify UFL1, a UFM1-specific E3 ligase, as a pivotal regulator of fork stability and the response to PARP inhibitors in BRCA1/2-deficient cells.. On replication stress, UFL1 localizes to stalled forks and catalyzes the UFMylation of PTIP, a component of the MLL3/4 methyltransferase complex, specifically at lysine 148.

    other:

    Article Title: The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation.
    Article Snippet: A human anti-SETD3 (A304-071A-2), anti-BRCA2 (A303434A), and anti-biotin antibodies (A150-109A) were purchased from Bethyl Laboratories.

    Article Title: The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation
    Article Snippet: A human anti-SETD3 (A304-071A-2), anti-BRCA2 (A303-434A), and anti-biotin antibodies (A150-109A) were purchased from Bethyl Laboratories.

    Immunoprecipitation:

    Article Title: PARP1 UFMylation ensures the stability of stalled replication forks
    Article Snippet: .. Immunoblotting, immunoprecipitation, pull-down assays and immunofluorescence First antibodies: anti-HA (A190-208A), anti-MYC (A190-205A), anti-UFL1 (A303455A, A303-456A), anti-PARP1 (A301-375A), anti-CHK1 (A300-298A), anti-BRCA2 (A303-434A), anti-RPA32 (A300-244A), and anti-pRPA32 (S33) (A300-246A) were purchased from Bethyl. .. Anti-PAR (ab14459), anti-BrdU (ab6326), anti-H3 (ab1791), and anti-MRE11 (ab214) was purchased from Abcam.

    Immunofluorescence:

    Article Title: PARP1 UFMylation ensures the stability of stalled replication forks
    Article Snippet: .. Immunoblotting, immunoprecipitation, pull-down assays and immunofluorescence First antibodies: anti-HA (A190-208A), anti-MYC (A190-205A), anti-UFL1 (A303455A, A303-456A), anti-PARP1 (A301-375A), anti-CHK1 (A300-298A), anti-BRCA2 (A303-434A), anti-RPA32 (A300-244A), and anti-pRPA32 (S33) (A300-246A) were purchased from Bethyl. .. Anti-PAR (ab14459), anti-BrdU (ab6326), anti-H3 (ab1791), and anti-MRE11 (ab214) was purchased from Abcam.



    Similar Products

    86
    Wanleibio brca2
    The potential function and pathways of TSF on DOX‐induced cardiotoxicity: (a) PPI network of 103 overlapping targets constructed based on the STRING database; (b) the PPI network map; (c) the molecular docking of HDAC8 with <t>BRCA2.</t>
    Brca2, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/anti+brca2/pmc13247116-42-2-9
    Average 86 stars, based on 1 article reviews
    brca2 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    93
    Proteintech brca2
    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or <t>BRCA2</t> (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.
    Brca2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/BRCA2+Antibody/pmc13048371-64-35-37
    Average 93 stars, based on 1 article reviews
    brca2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    86
    Merck & Co rabbit anti brca2
    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or <t>BRCA2</t> (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.
    Rabbit Anti Brca2, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/anti+cd31+primary+rabbit/bio_rxiv__64898__2026__03__20__713105-271-10-14
    Average 86 stars, based on 1 article reviews
    rabbit anti brca2 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti brca2 antibody
    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or <t>BRCA2</t> (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.
    Anti Brca2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/pmc12969137-6-0-3
    Average 86 stars, based on 1 article reviews
    anti brca2 antibody - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc brca2
    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or <t>BRCA2</t> (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.
    Brca2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/BRCA2+Rabbit+mAb/pm41740195-100-61-62
    Average 95 stars, based on 1 article reviews
    brca2 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti brca2
    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or <t>BRCA2</t> (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.
    Anti Brca2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/BACH1%2FBRIP1+Antibody/pmc13006209-83-48-49
    Average 93 stars, based on 1 article reviews
    anti brca2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    Bethyl anti brca2 rabbit
    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or <t>BRCA2</t> (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.
    Anti Brca2 Rabbit, supplied by Bethyl, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+brca2/BRCA2+Antibody/pmc12934461-8-0-3
    Average 94 stars, based on 1 article reviews
    anti brca2 rabbit - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    The potential function and pathways of TSF on DOX‐induced cardiotoxicity: (a) PPI network of 103 overlapping targets constructed based on the STRING database; (b) the PPI network map; (c) the molecular docking of HDAC8 with BRCA2.

    Journal: Food Science & Nutrition

    Article Title: Exploring the Mechanisms of Total Saponins of Black Ginseng and Ginsenoside Rg3 Against Doxorubicin‐Induced Cardiotoxicity

    doi: 10.1002/fsn3.71968

    Figure Lengend Snippet: The potential function and pathways of TSF on DOX‐induced cardiotoxicity: (a) PPI network of 103 overlapping targets constructed based on the STRING database; (b) the PPI network map; (c) the molecular docking of HDAC8 with BRCA2.

    Article Snippet: Antibodies for BRCA2, DRP1 and Bcl‐2 were sourced from Wanlei Biotechnology Co. Ltd. (Lot: T11052438, T09113028, T11201556), while β ‐actin and HRP‐labeled secondary antibodies were procured from Affinity Biosciences (Lot: T0022, S0001).

    Techniques: Construct

    TSF and Rg3 regulate HDAC8/BRCA2/DRP1 pathway inhibits DOX‐induced cardiomyocyte apoptosis. (a) Apoptosis was assessed using TUNEL staining (Scale bar = 50 μm). (b) The results of western blotting for each group. (c) The expression of Bcl‐2 for each group. (d) The expression of DRP1 for each group. (e) The expression of HDAC8 for each group. (f) The expression of BRCA2 for each group. (g) Immunofluorescence staining for observing the colocalization of HDAC8, BRCA2, and DRP1 (Scale bar = 1 mm). Data are expressed as mean ± standard from three individual experiments. Data analysis among groups was performed using ANOVA, with LSD for equal variances and Dunnett’s‐T3 for unequal variances, with significance levels of * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Food Science & Nutrition

    Article Title: Exploring the Mechanisms of Total Saponins of Black Ginseng and Ginsenoside Rg3 Against Doxorubicin‐Induced Cardiotoxicity

    doi: 10.1002/fsn3.71968

    Figure Lengend Snippet: TSF and Rg3 regulate HDAC8/BRCA2/DRP1 pathway inhibits DOX‐induced cardiomyocyte apoptosis. (a) Apoptosis was assessed using TUNEL staining (Scale bar = 50 μm). (b) The results of western blotting for each group. (c) The expression of Bcl‐2 for each group. (d) The expression of DRP1 for each group. (e) The expression of HDAC8 for each group. (f) The expression of BRCA2 for each group. (g) Immunofluorescence staining for observing the colocalization of HDAC8, BRCA2, and DRP1 (Scale bar = 1 mm). Data are expressed as mean ± standard from three individual experiments. Data analysis among groups was performed using ANOVA, with LSD for equal variances and Dunnett’s‐T3 for unequal variances, with significance levels of * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: Antibodies for BRCA2, DRP1 and Bcl‐2 were sourced from Wanlei Biotechnology Co. Ltd. (Lot: T11052438, T09113028, T11201556), while β ‐actin and HRP‐labeled secondary antibodies were procured from Affinity Biosciences (Lot: T0022, S0001).

    Techniques: TUNEL Assay, Staining, Western Blot, Expressing, Immunofluorescence

    The mechanism diagram of TSF and Rg3 alleviating DOX‐induced myocardial injury by regulating the HDAC8/BRCA2/DRP1 pathway.

    Journal: Food Science & Nutrition

    Article Title: Exploring the Mechanisms of Total Saponins of Black Ginseng and Ginsenoside Rg3 Against Doxorubicin‐Induced Cardiotoxicity

    doi: 10.1002/fsn3.71968

    Figure Lengend Snippet: The mechanism diagram of TSF and Rg3 alleviating DOX‐induced myocardial injury by regulating the HDAC8/BRCA2/DRP1 pathway.

    Article Snippet: Antibodies for BRCA2, DRP1 and Bcl‐2 were sourced from Wanlei Biotechnology Co. Ltd. (Lot: T11052438, T09113028, T11201556), while β ‐actin and HRP‐labeled secondary antibodies were procured from Affinity Biosciences (Lot: T0022, S0001).

    Techniques:

    (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or BRCA2 (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.

    Journal: PLOS One

    Article Title: Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition

    doi: 10.1371/journal.pone.0345514

    Figure Lengend Snippet: (A) . U2OS or Hela cells were transfected with Control (siCON), MCPH1 (siMCPH1) or BRCA2 (siBRCA2) siRNA for 48h or 120h and protein expression analysed via Western blotting with the indicated antibodies. MCPH1 expression in sgCON (control) and sgMCPH1 (MCPH1 knockout) cells was also investigated by Western blotting. (B) Quantification of MCPH1 or BRCA2 protein bands normalised to GAPDH and expressed as % change relative to siCON or sgCON. Data is the mean and standard error of three (48h) or two (120h and sgCON/sgMCPH1) independent experiments. (C) U2OS or Hela cells were transfected with MCPH1 siRNA for 72h before analysis of nuclear morphology (premature chromosome condensation, PCC) via DAPI staining and fluorescence microscopy. (D) The % of cells displaying PCC, with at least 100 cells analysed.

    Article Snippet: Membranes were blocked with 5% dried skimmed milk/TBS-T (50mM Tris pH 7.6, 150mM NaCl and 0.2% v/v Tween-20) for a minimum of 1-hour prior to overnight incubation at 4°C with primary antibodies; MCPH1 (11962–1-AP, Proteintech), BRCA2 (29450–1-AP, Proteintech) and GAPDH (60004–1-Ig, Proteintech).

    Techniques: Transfection, Control, Expressing, Western Blot, Knock-Out, Staining, Fluorescence, Microscopy

    U2OS cells were transfected with control (siCON), BRCA2 (siBRCA2) or BRCA2 + MCPH1 (siBRCA2 + siMCPH1) siRNA for 48h before (A) Western blot analysis or (B) seeding into 96-well plates and treating with the indicated doses of AZD2461 or Talazoparib, with each treatment performed in triplicate. After 96-hours, cell viability was measured using an MTS assay. MTS data represents the mean and standard error from at least three independent experiments, with cell viability expressed as a % relative to the corresponding untreated sample. Statistical significance was measured using two-way ANOVA (p-values described in text, with significance set at p < 0.05).

    Journal: PLOS One

    Article Title: Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition

    doi: 10.1371/journal.pone.0345514

    Figure Lengend Snippet: U2OS cells were transfected with control (siCON), BRCA2 (siBRCA2) or BRCA2 + MCPH1 (siBRCA2 + siMCPH1) siRNA for 48h before (A) Western blot analysis or (B) seeding into 96-well plates and treating with the indicated doses of AZD2461 or Talazoparib, with each treatment performed in triplicate. After 96-hours, cell viability was measured using an MTS assay. MTS data represents the mean and standard error from at least three independent experiments, with cell viability expressed as a % relative to the corresponding untreated sample. Statistical significance was measured using two-way ANOVA (p-values described in text, with significance set at p < 0.05).

    Article Snippet: Membranes were blocked with 5% dried skimmed milk/TBS-T (50mM Tris pH 7.6, 150mM NaCl and 0.2% v/v Tween-20) for a minimum of 1-hour prior to overnight incubation at 4°C with primary antibodies; MCPH1 (11962–1-AP, Proteintech), BRCA2 (29450–1-AP, Proteintech) and GAPDH (60004–1-Ig, Proteintech).

    Techniques: Transfection, Control, Western Blot, MTS Assay